Systemic pro-opiomelanocortin expression induces melanogenic differentiation and inhibits tumor angiogenesis in established mouse melanoma

Human Gene Therapy

Volumn 22, Issue 3, 2011, Pages 325-335

  Liu, Guei Sheung ^a,b   Tsai, Han En ^a,c   Weng, Wen Tsan ^d   Liu, Li Feng ^e   Weng, Chien Hui ^b   Chuang, Ming Ru ^a   Lam, Hing Chung ^a   Wu, Chieh Shan ^a   Tee, Richard ^b   Wen, Zhi Hong ^c   Howng, Shen Long ^f   Tai, Ming Hong ^a,b,c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA INTERMEDIN; BETA INTERMEDIN; CORTICOTROPIN; PROOPIOMELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC GENE THERAPY; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE; GROWTH INHIBITION; HISTOLOGY; MELANOGENESIS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SURVIVAL TIME; SYSTEMIC CIRCULATION; SYSTEMIC THERAPY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; GENE THERAPY; GENETIC VECTORS; HEK293 CELLS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; PRO-OPIOMELANOCORTIN; SURVIVAL ANALYSIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE; MUS;

EID: 79952631762     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.090     Document Type: Article

References (30)

1. Catania, A., Colombo, G., Carlin, A., Garofalo, L., Gatti, S., Buffa, R., Carboni, N., Rosso, L., Santambrogio, L., Cantala-messa, L., and Lipton, J.M. (2004). Autocrine inhibitory influences of a-melanocyte-stimulating hormone in malignant pleural mesothelioma. J. Leukoc. Biol. 75, 253-259. (Pubitemid 38174582)
2. Coussens, L.M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867. (Pubitemid 36019639)
3. Crosby, T., Fish, R., Coles, B., and Mason, M.D. (2000). Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst. Rev 2000, CD001215.
4. Elder, D.E., Gimotty, P.A., and Guerry, D. (2005). Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatol. Ther. 18, 369-385. (Pubitemid 43096610)
5. Folkman, J. (2006). Angiogenesis. Annu. Rev. Med. 57, 1-18. (Pubitemid 43261975)
6. Geller, A.C., Swetter, S.M., Brooks, K., Demierre, M.F., and Yaroch, A.L. (2007). Screening, early detection, and trends for melanoma: current status (2000-2006) and future directions. J. Am. Acad. Dermatol. 57, 555-572; quiz 573-576. (Pubitemid 47384936)
7. Hill, S.E., Buffey, J., Thody, A.J., Oliver, I., Bleehen, S.S., and MacNeil, S. (1989). Investigation of the regulation of pigmentation in a-melanocyte-stimulating hormone responsive and unresponsive cultured B16 melanoma cells. Pigment Cell Res. 2, 161-166.
8. Hlatky, L., Hahnfeldt, P., and Folkman, J. (2002). Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us. J. Natl. Cancer Inst. 94, 883-893. (Pubitemid 34778087)
9. Jacob, K., Wach, F., Holzapfel, U., Hein, R., Lengyel, E., Buettner, R., and Bosserhoff, A.K. (1998). In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res. 8, 211-219. (Pubitemid 28313758)
10. Kameyama, K., Vieira, W.D., Tsukamoto, K., Law, L.W., and Hearing, V.J. (1990). Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells. Int. J. Cancer 45, 1151-1158. (Pubitemid 20201589)
11. Kulesa, P.M., Kasemeier-Kulesa, J.C., Teddy, J.M., Margaryan, N.V., Seftor, E.A., Seftor, R.E., and Hendrix, M.J. (2006). Re-programming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc. Natl. Acad. Sci. U.S.A. 103, 3752-3757. (Pubitemid 43376627)
12. Lam, H.C., Kuo, S.M., Chuang, M.J., Keng, H.M., Lin, P.R., Liu, G.S., Hsu, C.M., Howng, S.L., and Tai, M.H. (2006). Blockade of endothelin-1 release contributes to the anti-angiogenic effect by pro-opiomelanocortin overexpression in endothelial cells. Exp. Biol. Med. (Maywood) 231, 782-788.
13. Leszczyniecka, M., Roberts, T., Dent, P., Grant, S., and Fisher, P.B. (2001). Differentiation therapy of human cancer: basic science and clinical applications. Pharmacol. Ther. 90, 105-156. (Pubitemid 32926714)
14. Liu, G.S., Liu, L.F., Lin, C.J., Tseng, J.C., Chuang, M.J., Lam, H.C., Lee, J.K., Yang, L.C., Chan, J.H., Howng, S.L., and Tai, M.H. (2006). Gene transfer of pro-opiomelanocortin pro-hormone suppressed the growth and metastasis of melanoma: Involvement of a-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kB/cyclooxygenase-2 pathway. Mol. Pharmacol. 69, 440-451. (Pubitemid 43121941)
15. Liu, G.S., Huang, H.T., Lin, C.J., Shi, J.Y., Liu, L.F., Tseng, R.T., Weng, W.T., Lam, H.C., Wen, Z.H., Cheng, T.L., Hsu, K.S., and Tai, M.H. (2009a). Prophylactic proopiomelanocortin expression alleviates capsaicin-induced neurogenic inflammation in rat trachea. Shock 32, 645-650.
16. Liu, G.S., Shi, J.Y., Lai, C.L., Hong, Y.R., Shin, S.J., Huang, H.T., Lam, H.C., Wen, Z.H., Hsu, K.S., Howng, S.L., and Tai, M.H. (2009b). Peripheral gene transfer of glial cell-derived neuro-trophic factor ameliorates the neuropathic deficits in diabetic rats. Hum. Gene Ther. 20, 715-727.
17. Manna, S.K., and Aggarwal, B.B. (1998). a-Melanocyte-stimu-lating hormone inhibits the nuclear transcription factor NF-kB activation induced by various inflammatory agents. J. Immunol. 161, 2873-2880. (Pubitemid 28425709)
18. Marcoval, J., Moreno, A., Graells, J., Vidal, A., Escriba, J.M., Garcia-Ramirez, M., and Fabra, A. (1997). Angiogenesis and malignant melanoma: Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J. Cutan. Pathol. 24, 212-218. (Pubitemid 27187016)
19. Murata, J., Ayukawa, K., Ogasawara, M., Fujii, H., and Saiki, I. (1997). a-Melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells. Invasion Metastasis 17, 82-93. (Pubitemid 28140323)
20. Pereda, M.P., Hopfner, U., Pagotto, U., Renner, U., Uhl, E., Arzt, E., Missale, C., and Stalla, G.K. (1999). Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion. Br. J. Cancer 81, 381-386. (Pubitemid 29458789)
21. Raffin-Sanson, M.L., De Keyzer, Y., and Bertagna, X. (2003). Proopiomelanocortin, a polypeptide precursor with multiple functions: From physiology to pathological conditions. Eur. J. Endocrinol. 149, 79-90. (Pubitemid 36987148)
22. Smalley, K., and Eisen, T. (2000). The involvement of p38 mitogen-activated protein kinase in the a-melanocyte stimulating hormone (a-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells. FEBS Lett. 476, 198-202. (Pubitemid 30410817)
23. Smalley, K.S., and Eisen, T.G. (2002). Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest. Melanoma Res. 12, 187-192. (Pubitemid 34666808)
24. Solomon, S. (1999). POMC-derived peptides and their biological action. Ann. N. Y. Acad. Sci. 885, 22-40.
25. Strasberg Rieber, M., and Rieber, M. (1995). Suppression of cy-clin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation. Biochem. Biophys. Res. Commun. 216, 422-427.
26. Streit, M., and Detmar, M. (2003). Angiogenesis, lymphangio-genesis, and melanoma metastasis. Oncogene 22, 3172-3179.
27. Tai, M.H., Kuo, S.M., Liang, H.T., Chiou, K.R., Lam, H.C., Hsu, C.M., Pownall, H.J., Chen, H.H., Huang, M.T., and Yang, C.Y. (2006). Modulation of angiogenic processes in cultured endo-thelial cells by low density lipoproteins subfractions from patients with familial hypercholesterolemia. Atherosclerosis 186, 448-457.
28. Thompson, J.F., Scolyer, R.A., and Kefford, R.F. (2005). Cutaneous melanoma. Lancet 365, 687-701. (Pubitemid 40260892)
29. Vacca, A., Ria, R., Ribatti, D., Bruno, M., and Dammacco, F. (2000). [Angiogenesis and tumor progression in melanoma]. Recenti Prog. Med. 91, 581-587.
30. Wu, X.S., Rao, K., Zhang, H., Wang, F., Sellers, J.R., Matesic, L.E., Copeland, N.G., Jenkins, N.A., and Hammer, J.A., III. (2002). Identification of an organelle receptor for myosin-Va. Nat. Cell Biol. 4, 271-278. (Pubitemid 34308852)